CARA Stock Continues to Rise: Reasons to Watch This BioTech Stock
A biotechnology company firmly on the radar is Cara Therapeutics (NASDAQ:CARA). The US-based drug developer was recently successful in its trialing of lead candidate Korsuva. At the end of May, CARA stock popped as the ... [Read]
CARA Stock Skyrockets 20% After Positive Results On KORSUVA
CARA stock is on fire as Cara Therapeutics Inc (NASDAQ:CARA) reported positive topline results from a Phase 3 clinical trial, KALM-1, evaluating KORSUVA. Cara’s KORSUVA Successful As far as therapeutics companies are concerned, the completion ... [Read]